Remarkably, we also find that hTERT-RPE1 cells engineered to mimic the effects of cancer-associated mutations in the p53-phosphatase WIP1 attenuate DNA damage signalling and circumvent this response, enabling damaged cells to enter mitosis, divide, and enter the next cell cycle. The gene discussed is TP53; the disease is cancer.